Fungal Infections are a rising challenge in global health because of the increasing number of immuno-compromised patients, shortage of antifungal drugs, and increased resistance. Medicinal plants have been investigated as alternative sources of antifungal agents because of their diversity, bioactivities, and safety. Among these, Hibiscus rosa-sinensis and Bougainvillea spectabilis have been scientifically studied because of their various phytochemical constituents and broad-spectrum antimicrobial properties. Several in vitro and in vivo studies have demonstrated the antifungal efficacy of different parts of these plants, such as leaves, flowers, stems, and roots, against fungi, Candida, dermatophytes, and filamentous fungi. This review summarizes the antifungal activities of Hibiscus rosa-sinensis and Bougainvillea spectabilis.
Prashar et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: